No abstract available
Plain language summary
This study assesses the risk of venous thromboembolism of different forms of hormonal contraception, including pills with estrogen and progestin, vaginal rings, patches, progestin-only pills, intrauterine devices, implants, and injections.
PubMed Disclaimer
Conflict of interest statement
Conflict of Interest Disclosures: Dr Yonis reported grants from TrygFonden and Laerdal outside the submitted work. Dr Løkkegaard reported personal fees from Pfizer, compensation to the hospital from Astellas for a 1-day meeting, and salary for PhD student from Radiometer for validating blood gas analyses during the conduct of the study. Dr Kragholm reported personal fees from Novo Nordisk (speaker’s honorarium) outside the submitted work. Dr Torp-Pedersen reported grants from Novo Nordisk for an epidemiological study and Bayer for a randomized study outside the submitted work. No other disclosures were reported.
References
-
-
Stegeman BH, de Bastos M, Rosendaal FR, et al. Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis. BMJ. 2013;347:f5298-f5298. doi: 10.1136/bmj.f5298
-
DOI
-
PMC
-
PubMed
-
-
Lidegaard Ø, Nielsen LH, Skovlund CW, Skjeldestad FE, Løkkegaard E. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9. BMJ. 2011;343:d6423. doi: 10.1136/bmj.d6423
-
DOI
-
PMC
-
PubMed
-
-
Sundbøll J, Adelborg K, Munch T, et al. Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study. BMJ Open. 2016;6(11):e012832. doi: 10.1136/bmjopen-2016-012832
-
DOI
-
PMC
-
PubMed
-
-
Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(7)(suppl):38-41. doi: 10.1177/1403494810394717
-
DOI
-
PubMed